Thymogen (Thymagen): Research Overview
Two-amino-acid peptide isolated from thymus extract, registered in Russia since 1990.
Also known as Thymagen · EW dipeptide · Glu-Trp
What is Thymogen?
Thymogen (EW dipeptide) is a Khavinson bioregulator consisting of glutamic acid and tryptophan, originally isolated from calf thymus extracts (Thymalin) in the late 1980s. Developed by Professor Vladimir Khavinson, it has been registered in Russia since 1990 in multiple forms including injectable solution, nasal spray, and topical cream.
What is Thymogen researched for?
- Modulates both humoral and cellular immune responses for balanced immunity.
- Activates T-cell differentiation and normalizes CD3+, CD4+, CD8+ populations.
- Stimulates production of IgA, IgG, IgE, and IgM antibodies.
- Studied for improving surgical outcomes through immune support.
- Demonstrated geroprotector activity in aging research.
- In combination with pineal peptides, showed significant mean lifespan increases in animal models.
- Inhibits spontaneous carcinogenesis and shows robust antitumor effects in research.
- Studied in Russia for regulating immune response in oncology patients.
- Research interest in cardiovascular applications.
- Investigated for metabolic and immune aspects of diabetes.
How does Thymogen work?
Thymogen works through multiple immunomodulatory mechanisms: (1) activates T-cell differentiation and T-cell recognition of peptide-MHC complexes, (2) induces changes in intracellular cyclic nucleotide composition, (3) activates neutrophilic chemotaxis and phagocytosis, (4) normalizes T-lymphocyte concentrations and ratios (CD3+, CD4+, CD8+), (5) stimulates production of immunoglobulins (IgA,…
References
Anisimov VN, Khavinson VK, Morozov VG · Biogerontology · 2000
Thymogen demonstrated geroprotector activity and inhibited spontaneous carcinogenesis in aging rat models.
Animal study · PMID 11707921
Natural and synthetic thymic peptides as therapeutics for immune dysfunction
Morozov VG, Khavinson VK · International journal of immunopharmacology · 1997
Review of thymic peptide therapeutics including Thymogen for immune modulation.
PMID 9637345
Peptide Bioregulators from
Thymus and Pineal Gland Khavinson VKh et al. · Biogerontology · 2003
Significant lifespan increases and antitumor activity with combined Thymogen and Epitalon treatment.
Thymogen: Mechanism of Action Studies Russian Medical Research Thymogen activates T-cell differentiation, modulates cyclic nucleotides, and may interact with AACG DNA sequences.
Thymogen activates T-cell differentiation, modulates cyclic nucleotides, and may interact with AACG DNA sequences.
Common questions
What's the difference between Thymogen (EW dipeptide) and Thymalin (extract mixture)?
Thymogen is a single, pure dipeptide (Glu-Trp) isolated from Thymalin extracts. Thymalin is the complete mixture containing multiple peptides (KE, EW, EDP). Thymogen offers standardized dosing and stability, while Thymalin provides broader synergistic effects - both are compatible and sometimes used together.
How do Thymogen and Epitalon compare for anti-aging and lifespan extension?
Both are Khavinson anti-aging peptides with different targets. Thymogen focuses on immune rejuvenation and tumor suppression, while Epitalon targets pineal/endocrine aging. Combined use showed robust lifespan increases and antitumor activity in research models - they're synergistic rather than redundant.
Is Thymogen banned in sports like other immune peptides?
Thymogen is not explicitly listed as banned by WADA since it's not widely used in sports, but as a performance-enhancing immune modulator, it would likely be prohibited if tested. Check with your sport's governing body, but assume risk if subject to anti-doping testing.